Celtaxsys Inc. corralled a stable of investors, led by Domain Partners, to complete a $40 million series D round that was supplemented by an additional $5 million grant from Cystic Fibrosis (CF) Foundation Therapeutics, the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF).